gefitinib genthon 250 mg film-coated tablets
genthon bv microweg 22, 6545 cm nijmegen, netherlands - gefitinib - film-coated tablet - gefitinib 250 mg - antineoplastic agents
gefinor tablet, film coated 250mg
ethypharm 194 bureaux de la colline, bâtiment d, 92213 saint-cloud cedex, france - gefitinib - film-coated tablet - gefitinib 250 mg - antineoplastic agents
ingefitinib film coated tablet 250mg
intega pte ltd - gefitinib - tablet, film coated - gefitinib 250.00 mg
gefinorm-250 250mg film-coated tablet
(for) unicare healthsciences pvt. ltd.; importer: s.m.h.p. marketing & consultancy; distributor: s.m.h.p. marketing & consultancy - gefitinib - film-coated tablet - 250mg
gefinorm-250 250mg film-coated tablet
bliss pharma distribution and consultancy corp.; distributor: elebassy medical trading - gefitinib - film-coated tablet - 250mg
gefinix tablet
beacon pharmaceuticals plc - gefitinib - tablet - 250 mg
mastergraft putty - bone implant material, biological, animal-source
medtronic australasia pty ltd - 46425 - bone matrix implant, animal-derived, bioabsorbable - mastergraft? putty is supplied as a sterile, dry, solid, construct that is hydrated for single patient use and is a mouldable form of bone void filler. mastergraft? products are biocompatible, osteoconductive, porous implants that allows for bony in growth across the graft site while resorbing at a rate consistent with bone healing. mastergraft? putty is intended to help fill voids or gaps in bone, which may be surgically created osseous defects, or osseous defects caused by traumatic injury to the bone. mastergraft? putty provides a bone void filler that is resorbed and is replaced with bone during the natural healing process. the putty when combined with either autogenous bone marrow, and/or sterile water, and/or autograft is indicated as a bone void filler for bony voids or gaps that are not intrinsic to the stability of the bony structure. additionally, mastergraft putty can be used with autograft as a bone extender. specific indications for use include oral/maxillofacial augmentation or reconstruction.
solagé solution
glaxosmithkline inc - tretinoin; mequinol - solution - 0.01%; 2% - tretinoin 0.01%; mequinol 2% - cell stimulants and proliferants
ozanex cream
ferrer internacional, s.a. - ozenoxacin - cream - 1% - ozenoxacin 1% - antibiotics
farmalinx fumigrain fumigation tablets
farmalinx pty ltd - phosphine present as aluminium phosphide - tablet (inc. pellet, bolus, suppository, capsule) - phosphine present as aluminium phosphide phosphine active 330.0 g/kg - insecticide